Collegium Pharmaceutical (COLL) announced the appointment of Nancy Lurker to its Board of Directors, effective February 4, 2025. Lurker most recently served as President and CEO of EyePoint Pharmaceuticals (EYPT) until 2023, when she transitioned to the role of Executive-Vice Chair of its Board of Directors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COLL:
- Collegium Pharmaceutical price target lowered to $36 from $37 at Piper Sandler
- Collegium Pharmaceutical upgraded to Buy from Hold at Needham
- Drugmakers Raise the Prices on 583 Products to Start 2025
- Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz
- Collegium Pharmaceutical Unveils 2025 Financial Projections